Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options If you suffered losses in Nutex between August 8, 2024 and August 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leadi ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Nutex (NUTX) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Nutex between August 8, 2024 and August 14, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar ...

NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- WHY: New York, N.Y., October 6, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), of the important October 21, 2025 lead plaintiff deadline. SO WHAT: If you purchased Nutex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a ...

Core Insights - Nutex Health Inc. announced it received 20 awards and honors in Q3 2025, marking the highest number in the company's history [1] - The recognition is attributed to the company's focus on patient care, which is central to its operations [2] - Awards reflect community votes, indicating high patient satisfaction and service quality [3] Awards and Recognitions - Albuquerque ER & Hospital: Best Emergency Room/Urgent Care, Best Place to Work, Best Pediatric Emergency Room, Best Community Health [4] - Green Bay ER & Hospital: Best Hospital/Medical Center [4] - Tucson ER & Hospital: Best Emergency Room, Best Hospital, Best Children's Medical Center, Best Emergency Care [4] - New Braunfels ER & Hospital: Best Hospital [4] - Texarkana Emergency Center and Hospital: Best Emergency Care, Best Hospital [4] - NW Indiana ER & Hospital: Best Hospital [4] - Oklahoma ER & Hospital: CIHQ Accreditation [4] - Starkey Ranch ER & Hospital: Horizon Award for Excellence in Patient Financial Experience [5] - Nutex Health ranked No. 2 in Houston's Top Performing Companies [5] Company Overview - Nutex Health Inc. is headquartered in Houston, Texas, and was founded in 2011 [5] - The company operates two divisions: Hospital Division and Population Health Management Division [6] - The Hospital Division manages 24 facilities across 11 states, focusing on innovative healthcare models [6]

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Nutex between August 8, 2024 and August 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 05, 2025 (GLOBE NEWSWIRE) -- Faruqi & Far ...

Core Viewpoint - Nutex Health Inc. is facing a class action lawsuit due to allegations of securities fraud related to its dealings with HaloMD, which reportedly engaged in fraudulent activities to benefit Nutex financially [3][5]. Group 1: Allegations and Impact - On July 22, 2025, a report by Blue Orca Capital claimed that HaloMD was involved in a fraudulent scheme that resulted in significant financial losses for insurance companies, leading to a decline in Nutex's share price by approximately 10.05% [3]. - Following Nutex's announcement on August 14, 2025, regarding a delay in filing its quarterly report due to accounting adjustments, the company's share price fell by about 16.39% [4]. Group 2: Details of the Lawsuit - The lawsuit covers investors who purchased Nutex securities from August 8, 2024, to August 14, 2025, alleging that Nutex made misleading statements and failed to disclose critical information regarding its financial practices and the sustainability of its revenue [5]. - Specific allegations include that Nutex overstated its financial health, mismanaged stock-based compensation obligations, and failed to adequately address weaknesses in its internal controls over financial reporting [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Nutex Health Inc. securities between August 8, 2024, and August 14, 2025, about the October 21, 2025, lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Nutex securities during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by October 21, 2025 [2]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3]. Group 2: Allegations Against Nutex - The lawsuit alleges that Nutex made false and misleading statements, including claims about its financial reporting and internal controls [4]. - Specific allegations include that Nutex's revenues from a third-party vendor, HaloMD, were unsustainable due to fraudulent activities [4]. - The lawsuit claims that Nutex overstated its ability to remediate weaknesses in its financial reporting, leading to improper accounting of stock-based compensation obligations [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Nutex Health Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on October 21, 2025, for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Nutex securities between August 8, 2024, and August 14, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by the deadline [2]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3]. Group 2: Case Allegations - The lawsuit alleges that Nutex made false and misleading statements regarding its financial practices and internal controls, particularly concerning its relationship with HaloMD, a third-party vendor [4]. - Specific claims include that Nutex engaged in fraudulent activities to inflate revenues and overstated its ability to remediate internal control weaknesses [4]. - The lawsuit asserts that these misrepresentations led to an inability to accurately account for stock-based compensation obligations, increasing the risk of delayed financial reporting to the SEC [4].

LOS ANGELES, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming October 21, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR NUTEX INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECO ...

Core Points - A class action lawsuit has been filed against Nutex Health Inc. for allegedly making materially false and misleading statements regarding its business operations and financial prospects during the Class Period from August 8, 2024, to August 14, 2025 [8] - The lawsuit claims that Nutex engaged in fraudulent activities through its partnership with HaloMD, leading to unsustainable revenue and overstated financial health [3] - Investors who suffered losses during the specified period are encouraged to contact Bragar Eagel & Squire for legal options [4] Allegation Details - The complaint alleges that Nutex's management made false statements about the company's business and operations, including the success of its arbitration results with HaloMD [3] - It is claimed that Nutex overstated its ability to remediate internal control weaknesses and improperly classified stock-based compensation obligations [3] - The allegations suggest that these misrepresentations increased the risk of delayed financial reporting to the SEC and inflated the company's financial prospects [3] Next Steps - Investors who purchased Nutex shares and experienced losses are invited to reach out to the law firm for more information or to discuss their rights [4] - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is October 21, 2025 [8]